[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]

Giovanna Mantini; Anna R.Ita Alitto; Bruno Fionda; Vincenzo Frascino; Gian Carlo Mattiucci; Mario Balducci; Alessio G.Iuseppe Morganti; Alessio Giuseppe Morganti; Vincenzo Valentini

doi:10.5301/RU.2013.11499

[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]

Translated title of the contribution: [Autom. eng. transl.] [Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]

Giovanna Mantini, Anna R.Ita Alitto, Bruno Fionda, Vincenzo Frascino, Gian Carlo Mattiucci, Mario Balducci, Alessio G.Iuseppe Morganti, Alessio Giuseppe Morganti, Vincenzo Valentini

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are various and without proved superiority. Radiotherapy (RT) plays a key role in the disease history. Technological evolution with Intensity Modulate Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) allowed improvement, with significant results on local control and survival. Hypofractionation, Stereotactic Body RT (SBRT) and new brachytherapy approachs are still under investigation, with promising opportunities. Adjuvant vs salvage postoperative RT, hormone association, prophylactic pelvic irradiation are still under debate, but guidelines express overlapping indications. Multidisciplinary managements will be the future for care optimization, providing the best tool for  holistic and informed patients’ choice.

Translated title of the contribution	[Autom. eng. transl.] [Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]
Original language	Italian
Pages (from-to)	188-201
Number of pages	14
Journal	Urologia
Volume	80
DOIs	https://doi.org/10.5301/RU.2013.11499
Publication status	Published - 2013

Keywords

prostata

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5301/RU.2013.11499

Cite this

@article{06c40c28430b49c08f165d5345d5c31c,

title = "[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]",

abstract = "Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are various and without proved superiority. Radiotherapy (RT) plays a key role in the disease history. Technological evolution with Intensity Modulate Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) allowed improvement, with significant results on local control and survival. Hypofractionation, Stereotactic Body RT (SBRT) and new brachytherapy approachs are still under investigation, with promising opportunities. Adjuvant vs salvage postoperative RT, hormone association, prophylactic pelvic irradiation are still under debate, but guidelines express overlapping indications. Multidisciplinary managements will be the future for care optimization, providing the best tool for  holistic and informed patients{\textquoteright} choice.",

keywords = "prostata, prostata",

author = "Giovanna Mantini and Alitto, {Anna R.Ita} and Bruno Fionda and Vincenzo Frascino and Mattiucci, {Gian Carlo} and Mario Balducci and Morganti, {Alessio G.Iuseppe} and Morganti, {Alessio Giuseppe} and Vincenzo Valentini",

year = "2013",

doi = "10.5301/RU.2013.11499",

language = "Italian",

volume = "80",

pages = "188--201",

journal = "Urologia",

issn = "0391-5603",

publisher = "Sage Publications",

}

TY - JOUR

T1 - [Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]

AU - Mantini, Giovanna

AU - Alitto, Anna R.Ita

AU - Fionda, Bruno

AU - Frascino, Vincenzo

AU - Mattiucci, Gian Carlo

AU - Balducci, Mario

AU - Morganti, Alessio G.Iuseppe

AU - Morganti, Alessio Giuseppe

AU - Valentini, Vincenzo

PY - 2013

Y1 - 2013

N2 - Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are various and without proved superiority. Radiotherapy (RT) plays a key role in the disease history. Technological evolution with Intensity Modulate Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) allowed improvement, with significant results on local control and survival. Hypofractionation, Stereotactic Body RT (SBRT) and new brachytherapy approachs are still under investigation, with promising opportunities. Adjuvant vs salvage postoperative RT, hormone association, prophylactic pelvic irradiation are still under debate, but guidelines express overlapping indications. Multidisciplinary managements will be the future for care optimization, providing the best tool for  holistic and informed patients’ choice.

AB - Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are various and without proved superiority. Radiotherapy (RT) plays a key role in the disease history. Technological evolution with Intensity Modulate Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) allowed improvement, with significant results on local control and survival. Hypofractionation, Stereotactic Body RT (SBRT) and new brachytherapy approachs are still under investigation, with promising opportunities. Adjuvant vs salvage postoperative RT, hormone association, prophylactic pelvic irradiation are still under debate, but guidelines express overlapping indications. Multidisciplinary managements will be the future for care optimization, providing the best tool for  holistic and informed patients’ choice.

KW - prostata

UR - http://hdl.handle.net/10807/62654

U2 - 10.5301/RU.2013.11499

DO - 10.5301/RU.2013.11499

M3 - Articolo

SN - 0391-5603

VL - 80

SP - 188

EP - 201

JO - Urologia

JF - Urologia

ER -

[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches]

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this